Hi Supermig, welcome to the forum. It's good that you got to talk with Stéfanie Laniel and she might have an open mind about esmoking. It would be good if you would post the contacts here so we know who is best to get in touch with, especially the person in charge of the esmoking dossier.
Stéfanie's view that esmoking history is not good - is that something to do with being linked to smoking and tobacco? I think a lot of people in positions of power will not like the similarities between esmoking and smoking. There isn't a lot we can do about that, esmoking obviously appeals to smokers. The best we can hope for is that it will show up favourably in comparison as a healthier option.
"... opacity surrounding the manufacturing of the e-liquid..." I think you mean the lack of regulation and openness of manufacturers regarding content, purity and toxicity. The eliquid is my biggest area of concern, I think that could easily be banned as an unproven, potentially dangerous substance by many governments.
Voluntary disclosure and privately funded testing by manufacturers and vendors would help our case. This will cost money, to cover costs we may have to be prepared to pay a premium for our products. User groups may be able to organise research as you suggest. That would be a good way to get subjects for long term clinical trials.
Stéfanie's view that esmoking history is not good - is that something to do with being linked to smoking and tobacco? I think a lot of people in positions of power will not like the similarities between esmoking and smoking. There isn't a lot we can do about that, esmoking obviously appeals to smokers. The best we can hope for is that it will show up favourably in comparison as a healthier option.
"... opacity surrounding the manufacturing of the e-liquid..." I think you mean the lack of regulation and openness of manufacturers regarding content, purity and toxicity. The eliquid is my biggest area of concern, I think that could easily be banned as an unproven, potentially dangerous substance by many governments.
Voluntary disclosure and privately funded testing by manufacturers and vendors would help our case. This will cost money, to cover costs we may have to be prepared to pay a premium for our products. User groups may be able to organise research as you suggest. That would be a good way to get subjects for long term clinical trials.